Asymptomatic Carotid Lesions and Cognitive Impairment: Does Intervention Play a Role?

This study was designed to determine the effect of carotid endarterectomy/angioplasty on early (baseline vs. 3 months) and late (baseline vs. >5 months) cognitive function in patients with asymptomatic lesions.

This systematic research included 31 non-randomized studies.

Regarding the immediate post-operative period, 24 of these papers reported significant improvement in cognitive function; one study reported significant deterioration; three showed mixed results (some scores improved and others worsened), and the rest showed no changes.

In the late post-operative period (that is, well after endarterectomy or angioplasty), one study reported worse cognitive function, another showed significant improvement, some obtained mixed results, and most showed no change from baseline.

These results showed a similar distribution when comparing small studies with larger ones, controlled vs. uncontrolled studies, studies that used endarterectomy vs. others that used angioplasty, and studies with longer or shorter follow-up.


Read also: HOST-EXAM: The Study that Challenges Aspirin as Long-Term Antiplatelet Therapy.


Conclusion

Intervention, whether it be endarterectomy or angioplasty, rarely improves long-term cognitive function (<2%). However, it rarely makes it worse (in fact, magnitude is similar: 2%).

In the long term, the vast majority of papers (69%) could not prove an improvement in cognitive function. Only a few studies indicated improvement. The rest reported no change.

Until we have new papers that better identify the most vulnerable patients (with poor functional reserve) or provide clear evidence that silent embolism from a diseased carotid artery does indeed lead to cognitive impairment, we will remain in a sea of speculation.

Original title: Effect of Carotid Interventions on Cognitive Function in Patients With Asymptomatic Carotid Stenosis: A Systematic Review.

Reference: Stefano Ancetti et al. Eur J Vasc Endovasc Surg. 2021 Aug 30;S1078-5884(21)00604-3. Online ahead of print. doi: 10.1016/j.ejvs.2021.07.012. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...